Publications for Magnus Vrethem
Co-author map based on ISI articles 2007-

Publications mentioned in social media 26 times*

Keywords

treatment taurine t sclerosis polyneuropathy plasma peripheral patients pain neuroborreliosis nerve natalizumab ms disease csf controls clinical cells blood antibodies

Journal Articles

Johan Mellergård, Måns Edström, Maria Jenmalm, Charlotte Dahle, Magnus Vrethem and Jan Ernerudh
  Increased B Cell and Cytotoxic NK Cell Proportions and Increased T Cell Responsiveness in Blood of Natalizumab-Treated Multiple Sclerosis Patients
  PLoS ONE, 2013, 8(12), e81685.
   Fulltext  PDF  

Bodil Persson, Magnus Vrethem, Nicola Murgia, Jonas Lindh, Anna-Lena Hällsten, Mats Fredrikson and Martin Tondel
  Urinary 2,5-hexanedione excretion in cryptogenic polyneuropathy compared to the general Swedish population
 
Altmetric usage: 2

  Journal of Occupational Medicine and Toxicology, 2013, 8, .
   Fulltext  PDF  

Maria Kvarnström, J Ydrefors, Christina Ekerfelt, Magnus Vrethem and Jan Ernerudh
  Longitudinal interferon-β effects in multiple sclerosis: differential regulation of IL-10 and IL-17A, while no sustained effects on IFN-γ, IL-4 or IL-13
 
Altmetric usage: 4

  Journal of the Neurological Sciences, 2013, 325(1-2), 79-85.
   Fulltext  PDF  

Martin Samuelsson, Elisabeth Skogh, Kristina Lundberg, Magnus Vrethem and Karin Öllinger
  Taurine and glutathione in plasma and cerebrospinal fluid in olanzapine treated patients with schizophrenia
  Psychiatry Research, 2013, 210(3), 819-824.

Magnus Vrethem, J Lindh, Martin Tondel, B Persson and Charlotte Dahle
  IgA antibodies against tissue transglutaminase, endomysium and gliadin in idiopathic polyneuropathy
 
Altmetric usage: 2

  Acta Neurologica Scandinavica, 2013, 127(2), 109-115.

H Tedeholm, J Lycke, B Skoog, V Lisovskaja, J Hillert, Charlotte Dahle, J Fagius, S Fredrikson, Anne-Marie Landtblom, C Malmestrom, C Martin, F Piehl, B Runmarker, L Stawiarz, Magnus Vrethem, O Nerman and O Andersen
  Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs
 
Altmetric usage: 6

  Multiple Sclerosis, 2013, 19(6), 765-774.
 Web of Science® Times Cited: 1

Magnus Vrethem, Kristina Malmgren and Jonas Lindh
  A patient with both narcolepsy and multiple sclerosis in association with Pandemrix vaccination
 
Altmetric usage: 1

  Journal of the Neurological Sciences, 2012, 321(1-2), 89-91.
 Web of Science® Times Cited: 2

Martin Samuelsson, George Gerdin, Karin Öllinger and Magnus Vrethem
  Taurine and glutathione levels in plasma before and after ECT treatment
  Psychiatry Research, 2012, 198(1), 53-57.
 Web of Science® Times Cited: 1

Johan Mellergård, Anders Tisell, Olof Dahlqvist Leinhard, Ida Blystad, Anne-Marie Landtblom, Kaj Blennow, Bob Olsson, Charlotte Dahle, Jan Ernerudh, Peter Lundberg and Magnus Vrethem
  Association between Change in Normal Appearing White Matter Metabolites and Intrathecal Inflammation in Natalizumab-Treated Multiple Sclerosis
 
Altmetric usage: 3

  PLoS ONE, 2012, 7(9), e44739.
   Fulltext  PDF  
 Web of Science® Times Cited: 1

Barbro H Skogman, Kajsa Glimaker, Maria Nordwall, Magnus Vrethem, Lars Ödkvist and Pia Forsberg
  Long-term Clinical Outcome After Lyme Neuroborreliosis in Childhood
 
Altmetric usage: 3

  Pediatrics, 2012, 130(2), 262-269.
 Web of Science® Times Cited: 2

Istvan Gati, Olof Danielsson, Cecilia Gunnarsson, Magnus Vrethem, Bo Häggqvist, Bengt-Arne Fredriksson and Anne-Marie Landtblom
  Letter: Bent Spine Syndrome: A Phenotype of Dysferlinopathy or a Symptomatic DYSF Gene Mutation Carrier
  European Neurology, 2012, 67(5), 300-302.
 Web of Science® Times Cited: 1

Magnus Vrethem, Maria Kvarnström, J Stenstam, Petra Cassel, M Gustafsson, Anne-Marie Landtblom and Jan Ernerudh
  Cytokine mapping in cerebrospinal fluid and blood in multiple sclerosis patients without oligoclonal bands
  Multiple Sclerosis, 2012, 18(5), 669-673.
 Web of Science® Times Cited: 3

Magnus Vrethem, Charlotte Dahle and Björn Lindvall
  Subacute neuronopathy in a young man: a possible association with tetracycline treatment
  Neurology international, 2011, 3(3), e16.

Magnus Vrethem, Mona Widhe, Jan Ernerudh, Ulf Garpmo and Pia Forsberg
  Clinical, diagnostic and immunological characteristics of patients with possible neuroborreliosis without intrathecal Ig-synthesis against Borrelia antigen in the cerebrospinal fluid
 
Altmetric usage: 2

  Neurology International, 2011, 3(1), .

Jonas Lindh, Peter Söderkvist, Mats Fredrikson, Shahzad Hosseininia, Martin Tondel, Bodil Persson and Magnus Vrethem
  Polymorphisms of GSTT1, GSTM1 and EPHX genotypes in patients with cryptogenic polyneuropathy: a case control study
  Brain and Behavior, 2011, , .

Jonas Lindh, Martin Tondel, Bodil Persson and Magnus Vrethem
  Health-related quality of life in patients with cryptogenic polyneuropathy compared with the general population
  DISABILITY AND REHABILITATION, 2011, 33(7), 617-623.
 Web of Science® Times Cited: 1

Martin Gunnarsson, Clas Malmestrom, Markus Axelsson, Peter Sundstrom, Charlotte Dahle, Magnus Vrethem, Tomas Olsson, Fredrik Piehl, Niklas Norgren, Lars Rosengren, Anders Svenningsson and Jan Lycke
  Axonal Damage in Relapsing Multiple Sclerosis is Markedly Reduced by Natalizumab
 
Altmetric usage: 3

  ANNALS OF NEUROLOGY, 2011, 69(1), 83-89.
 Web of Science® Times Cited: 38

Måns Edström, Johan Mellergård, Jenny Mjösberg, Maria Jenmalm, Magnus Vrethem, R Press, Charlotte Dahle and Jan Ernerudh
  Transcriptional characteristics of CD4+ T cells in multiple sclerosis: relative lack of suppressive populations in blood
  Multiple Sclerosis, 2011, 17(1), 57-66.
 Web of Science® Times Cited: 7

Magnus Vrethem, N. Reiser, C. Lauermann and Eva Svanborg
  Polyneuropathy associated with IgM vs IgG monoclonal gammopathy: comparison between clinical and electrophysiological findings
  Acta Neurologica Scandinavica, 2010, 122(1), 52-57.
 Web of Science® Times Cited: 2

Jakob Paues and Magnus Vrethem
  Fatal progressive multifocal leukoencephalopathy in a patient with non-Hodgkin lymphoma treated with rituximab
  Journal of Clinical Virology, 2010, 48(4), 291-293.
 Web of Science® Times Cited: 8

Johan Mellergård, Måns Edström, Magnus Vrethem, Jan Ernerudh and Charlotte Dahle
  Natalizumab treatment in multiple sclerosis: marked decline of chemokines and cytokines in cerebrospinal fluid
  Multiple Sclerosis, 2010, 16(2), 208-217.
   Fulltext  PDF  
 Web of Science® Times Cited: 28

Gunilla Margareta Liedberg and Magnus Vrethem
  Polyneuropathy, with and without neurogenic pain, and its impact on daily life activities - a descriptive study
  Disability and Rehabilitation, 2009, 31(17), 1402-1408.
 Web of Science® Times Cited: 5

Martin Tondel, Jonas Lindh, Pia Jönsson, Magnus Vrethem and B. Persson
  Occupational determinants of cryptogenic polyneuropathy
  Neuroepidemiology, 2006, 26(4), 187-194.
 Web of Science® Times Cited: 2

Elisabeth Hallin, Johan Mellergård, Magnus Vrethem, Jan Ernerudh and Christina Ekerfelt
  In vitro Th2 deviation of myelin-specific peripheral blood lymphocytes from patients with multiple sclerosis
  Journal of Neuroimmunology, 2006, 171( 1-2), 156-162.
 Web of Science® Times Cited: 2

Jonas Lindh, Martin Tondel, A. Osterberg and Magnus Vrethem
  Cryptogenic polyneuropathy: Clinical and neurophysiological findings
  Journal of the peripheral nervous system, 2005, 10(1), 31-37.
 Web of Science® Times Cited: 9

Magnus Vrethem, Ingrid Fernlund, Jan Ernerudh and Sten Öhman
  Prognostic value of cerebrospinal fluid IgA and IgG in multiple sclerosis
  Multiple Sclerosis, 2004, 10(4), 469-471.
 Web of Science® Times Cited: 3

Christina Ekerfelt, Jan Ernerudh, Pia Forsberg, Anna-Lena Jönsson, Magnus Vrethem, L Ärlehag and Urban Forsum
  Lyme borreliosis in Sweden - Diagnostic performance of five commercial Borrelia serology kits using sera from well-defined patient groups
  Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS), 2004, 112(1), 74-78.
 Web of Science® Times Cited: 8

Mona Widhe, Sara Jarefors, Christina Ekerfelt, Magnus Vrethem, Sven Bergström, Pia Forsberg and Jan Ernerudh
  Borrelia-specific interferon-γ and interleukin-4 secretion in cerebrospinal fluid and blood during Lyme borreliosis in humans: association with clinical outcome
  Journal of Infectious Diseases, 2004, 189(10), 1881-1891.
 Web of Science® Times Cited: 40

A. Jansson, Jan Ernerudh, Maria Kvarnström, Christina Ekerfelt and Magnus Vrethem
  Elispot assay detection of cytokine secretion in multiple sclerosis patients treated with interferon-β1a or glatiramer acetate compared with untreated patients
  Multiple Sclerosis, 2003, 9(5), 440-445.
 Web of Science® Times Cited: 13

Magnus Vrethem, E Mattsson, H Hebelka, K Leerbeck, A Österberg, Anne-Marie Landtblom, B Balla, H Nilsson, M Hultgren, L Brattström and Bertil Kågedal
  Increased plasma homocysteine levels without signs of vitamin B12 deficiency in patients with multiple sclerosis assessed by blood and cerebrospinal fluid homocysteine and methylmalonic acid
  Multiple Sclerosis, 2003, 9(3), 239-245.
 Web of Science® Times Cited: 33

Mona Widhe, Mattias Grusell, Christina Ekerfelt, Magnus Vrethem, Pia Forsberg and Jan Ernerudh
  Cytokines in Lyme borreliosis: lack of early tumour necrosis factor-α and transforming growth factor-β1 responses are associated with chronic neuroborreliosis
  Immunology, 2002, 107(1), 46-55.
 Web of Science® Times Cited: 23

Magnus Vrethem, L Hellblom, M Widlund, M Ahl, O Danielsson, Jan Ernerudh and Pia Forsberg
  Chronic symptoms are common in patients with neuroborreliosis - A questionnaire follow-up study
  Acta Neurologica Scandinavica, 2002, 106(4), 205-208.
 Web of Science® Times Cited: 35

Maria Kvarnström, E. Sidorova, Joakim Nilsson, Christina Ekerfelt, Magnus Vrethem, O. Söderberg, Malin Johansson, Anders Rosén and Jan Ernerudh
  Myelin protein P0-specific IgM producing monoclonal B cell lines were established from polyneuropathy patients with monoclonal gammopathy of undetermined significance (MGUS)
  Clinical and Experimental Immunology, 2002, 127(2), 255-262.
 Web of Science® Times Cited: 5

Magnus Vrethem, Jörgen Boivie, Hans Arnqvist, Helen Holmgren and Torbjörn Lindström
  Painful polyneuropathy in patients with and without diabetes: Clinical, neurophysiologic, and quantitative sensory characteristics
  The Clinical Journal of Pain, 2002, 18(2), 122-127.
 Web of Science® Times Cited: 13

Q Cheng, GX Jiang, S Fredrikson, H Link, J de Pedro-Cuesta and Magnus Vrethem
  Epidemiological surveillance of Guillain-Barré syndrome in Sweden, 1996-1997.
  Acta Neurologica Scandinavica, 2000, 101, 104-111.

Q. Cheng, GX Jiang, S Fredrikson, H Link, J de Pedro-Cuesta and Magnus Vrethem
  Incidence of Guillain-Barré syndrome in Sweden 1996.
  European Journal of Neurology, 2000, 7, 11-16.

Q. Cheng, GX Jiang, R. Press, M. Andersson, B. Ekstedt and Magnus Vrethem
  Clinical epidemiology of Guillain-Barre syndrome in Sweden 1996-1997: a prospective study.
  European Journal of Neurology, 2000, 7, 685-692.

Thomas Masterman, Arturs Ligers, Olle Olerup, Magnus Vrethem and Jan Hillert
  CTLA-4 dimorphisms in gammopathyassociateperipheral neuropathy.
  European Journal of Neurology, 1999, 6, 491-493.

G Solders, I Nennesmo, Jan Ernerudh, M Cruz and Magnus Vrethem
  Lymphocytes in sural nerve biopsies from patients with plasma cell dyscrasia and polyneuropathy. 
  Journal of the peripheral nervous system, 1999, 4, 91-98.

RA Elkarim, M Mustafa, H Link, M Bakhiet, Christina Ekerfelt, Magnus Vrethem and Jan Ernerudh
  Induction of neutralizing autoantibodies to interferon-gamma in patients with polyneuropathy.
  Human Antibodies, 1999, 9, 55-60.

Charlotte Dahle, Christina Ekerfelt, Magnus Vrethem, Margareta Samuelsson and Jan Ernerudh
  T helper type 2 like cytokine responses to peptides from P0 and P2 myelin proteins during the recovery phase of Guillain-Barré syndrome
  Journal of the Neurological Sciences, 1997, 153(1), 54-60.

Charlotte Dahle, Magnus Vrethem and Jan Ernerudh
  T lymphocyte subset abnormalities in peripheral blood from patients with the Guillain-Barré syndrome
  Journal of Neuroimmunology, 1994, 53(2), 219-225.

Conference Articles

Anders Tisell, Johan Mellergård, Olof Dahlqvist Leinhard, Charlotte Dahle, Jan Ernerudh, Magnus Vrethem, Anne-Marie Landtblom and Peter Lundberg
  Brain Atrophy in MS Patients Correlates with Creatine Concentrations
  ISMRM 20th Annual Meeting & Exhibition, 5-11 May, 2012, Melbourne, Australia, 2012.


Anders Tisell, Johan Mellergård, Olof Dahlqvist Leinhard, Charlotte Dahle, Jan Ernerudh, Magnus Vrethem, Anne-Marie Landtblom and Peter Lundberg
  Multiple Sclerosis Severity Score (MSSS) Correlates With Changes in NAWM Metabolism During Treatment
  ESMRMB, Leipzig 2011, 2011.


Anders Tisell, Johan Mellergård, Olof Dahlqvist Leinhard, Charlotte Dahle, Jan Ernerudh, Magnus Vrethem, Anne-Marie Landtblom and Peter Lundberg
  Increased Glia in Multiple Sclerosis Patients Correlates with Intrathecal Inflammation
  ESMRMB, Leipzig 2011, 2011.


Istvan Gati, Olof Danielsson, Magnus Vrethem, Hans Lindehammar, B Lindvall, Bo Häggqvist, Bengt-Arne Fredriksson and Anne-Marie Landtblom
  SENSORY ATAXIC NEUROPATHY WITH DYSARTHRIA/DYSPHAGIA AND OPHTHALMOPLEGIA (SANDO) - CASE HISTORIES in EUROPEAN JOURNAL OF NEUROLOGY, vol 18, issue SI, pp 282-282
  EUROPEAN JOURNAL OF NEUROLOGY, 2011.


Martin Tondel, Nicola Murgia, Bodil Persson, Jonas Lindh, Magnus Vrethem and Mats Fredrikson
  2,5-Hexanedione in the General Population: Environmental Exposure or Endogenous Production? in EPIDEMIOLOGY, vol 22, issue 1, pp S34-S35
  EPIDEMIOLOGY, 2011.


 Web of Science® Times Cited: 1

Johan Mellergård, Anders Tisell, Olof Dahlqvist Leinhard, Charlotte Dahle, Anne-Marie Landtblom, Jan Ernerudh, Peter Lundberg and Magnus Vrethem
  MR spectroscopy and quantitative MRI in multiple sclerosis patients treated with natalizumab: changes in normal appearing white matter are associated to intrathecal inflammation and clinical variables
  ECTRIMS 2010, 13-16 October 2010, Gothenburg, Sweden, 2010.


Martin Samuelsson, G. Gerdin and Magnus Vrethem
  Taurine levels in plasma before and after three ECT treatments in EUROPEAN NEUROPSYCHOPHARMACOLOGY, vol 20, issue , pp S426-S426
  EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010.


Måns Edström, Charlotte Dahle, Maria Jenmalm, Johan Mellergård, Jenny Mjösberg, Rayomand Press, Magnus Vrethem and Jan Ernerudh
  Th1/Th2/Th17 and Treg related transcription factors and cytokines in multiple sclerosis
  JOURNAL OF NEUROIMMUNOLOGY, 2008.


Ph.D. Theses

Martin Samuelsson
  Taurine and Glutathione in cerebrospinal fluid and plasma from patients with psychiatric disorders and healthy controls
  2012.


  Fulltext PDF

Johan Mellergård
  Immunological Mechanisms and Natalizumab Treatment in Multiple Sclerosis: Studies on lymphocytes, inflammatory markers and magnetic resonance spectroscopy
  2012.


  Fulltext PDF

Jonas Lindh
  Cryptogenic Polyneuropathy: Clinical, Environmental, And Genetic Studies
  2011.


  Fulltext PDF

Magnus Vrethem  Polyneuropathy associated with monoclonal gammopathy: A clinical, neurophysiological and immunological study
  1994.


* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.